Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the Answer of 23 May 2016 to Question 37122, on variations in access to transcatheter interventions for heart valve disease, whether the next iteration of the NHS England service specifications and policy for the surgical and interventional treatment of heart valve disease will take into account (a) the need to commission for a growing patient population, (b) anticipated doubling in the over-65 population in the UK by 2050 and (c) lower levels of transcatheter interventions performed in the UK compared to European comparator countries.

NHS England’s policy development process includes assessment of current published evidence nationally and internationally and will review population projections for up to five years.

Decisions to set commissioning criteria for which patients will most likely benefit from the intervention will be based on a range of clinical, academic and financial information and a proposition will be put forward through the NHS England prioritisation process. Within the transcatheter aortic valve implantation (TAVI) development process, NHS England accepts that there is an ageing population and it will review all available evidence including the encouraging results of the TAVI trials and consider the options around the best use of National Health Service resources. A policy proposition will be produced as part of the 2016/17 work programme.